Location of Repository

Acanthamoeba castellanii induces host cell death via a phosphatidylinositol 3-kinase-dependent mechanism

By J. Sissons, K.S. Kim, M. Stins, S. Jayasekera, S. Alsam and Naveed Ahmed Khan

Abstract

Granulomatous amoebic encephalitis due to Acanthamoeba castellanii is a serious human infection with fatal consequences, but it is not clear how the circulating amoebae interact with the blood-brain barrier and transmigrate into the central nervous system. We studied the effects of an Acanthamoeba encephalitis isolate belonging to the T1 genotype on human brain microvascular endothelial cells, which constitute the blood-brain barrier. Using an apoptosis-specific enzyme-linked immunosorbent assay, we showed that Acanthamoeba induces programmed cell death in brain microvascular endothelial cells. Next, we observed that Acanthamoeba specifically activates phosphatidylinositol 3-kinase. Acanthamoeba-mediated brain endothelial cell death was abolished using LY294002, a phosphatidylinositol 3-kinase inhibitor. These results were further confirmed using brain microvascular endothelial cells expressing dominant negative forms of phosphatidylinositol 3-kinase. This is the first demonstration that Acanthamoeba-mediated brain microvascular endothelial cell death is dependent on phosphatidylinositol 3-kinase

Topics: bcs
Publisher: American Society for Microbiology
Year: 2005
OAI identifier: oai:eprints.bbk.ac.uk.oai2:203

Suggested articles

Preview

Citations

  1. (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).
  2. Acanthamoeba induces cell-cycle arrest in the host cells. doi
  3. (2003). Acanthamoeba interactions with human brain microvascular endothelial cells. doi
  4. (1992). Acanthamoeba meningoencephalitis in an AIDS patient: first report from Europe.
  5. (1975). Acanthamoeba polyphaga keratitis and Acanthamoeba uveitis associated with fatal meningoencephalitis.
  6. (2003). Acanthamoeba spp. as agents of disease in humans. doi
  7. (1986). Acquired immunodefiency syndrome associated with Acanthamoeba infection and other opportunistic organisms.
  8. (2002). ADP and other metabolites released from Acanthamoeba castellanii lead to human monocytic cell death through apoptosis and stimulate the secretion of proinflammatory cytokines. doi
  9. (1994). Apoptosis as a mechanism of cytolysis of tumor cells by a pathogenic freeliving amoeba.
  10. (1998). Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway.
  11. (1999). Cellular survival: a play in three Akts. Genes Dev. doi
  12. (1987). Clinical manifestations of free-living amoebic infections,
  13. (1992). Culture isolation of Acanthamoeba species and leptomyxid amoebas from patients with amebic meningoencephalitis, including two patients with AIDS. doi
  14. (2001). Cytopathic changes in rat microglial cells induced by pathogenic Acanthamoeba culbertsoni: morphology and cytokine release. doi
  15. (2002). Cytotoxic necrotizing factor-1 contributes to Escherichia coli K1 invasion of the central nervous system. doi
  16. (1998). Direct targets of phosphoinositide 3-kinase products in membrane traffic and signal transduction. Trends Cell Biol. doi
  17. (1992). Disseminated Acanthamoeba infection in a child with symptomatic human immunodeficiency virus infection. doi
  18. (2001). Free-living amebas and the immune deficient host,
  19. (2004). Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. doi
  20. (1997). Free-living, amphizoic and opportunistic amebas. Brain Pathol. doi
  21. (2000). Integrin-linked kinase (ILK): a “hot” therapeutic target. doi
  22. (2004). Interferonalpha induced apoptosis in tumor cells is mediated through PI3K/mTOR signaling pathway. doi
  23. (1999). Involvement of tyrosine phosphorylation in HMG-CoA reductase inhibitor-induced cell death in L6 myoblasts. doi
  24. (2000). LY294002 structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, quercetin, myricetin, and staurosporine. doi
  25. (2003). Pathogenesis of Acanthamoeba infections. doi
  26. (2001). Pathogenicity, morphology, and differentiation of Acanthamoeba. doi
  27. (2000). Phosphatidylinositol 3-kinase activation and interaction with focal adhesion kinase in Escherichia coli K1 invasion of human brain microvascular endothelial cells. doi
  28. (1996). Phosphoinositide kinases. doi
  29. (2001). Phosphorylation of proteins and apoptosis induced by c-Jun N-terminal kinase1 activation in rat cardiomyocytes by H2O2 stimulation. doi
  30. (2002). PKB binding proteins: getting in on the Akt. Cell 111:293–303. doi
  31. (2000). Proteases as markers of differentiation of pathogenic and non-pathogenic Acanthamoeba. doi
  32. (1997). Selective expression of adhesion molecules on human brain microvascular endothelial cells. doi
  33. (1999). Signalling through phosphoinositide 3-kinases: the lipids take centre stage. doi
  34. (1995). The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates.
  35. (2003). The K1 capsule modulates trafficking of E. coli-containing vacuoles and enhances intracellular bacterial survival in human brain microvascular endothelial cells. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.